In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia ...
Napo Pharmaceuticals has submitted an orphan drug designation application to the U.S. Food and Drug Administration (FDA) for ...
In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally SAN FRANCISCO, CA ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Abbott Elementary’ star Tyler James Williams opens up to PEOPLE exclusively about his battle with Crohn’s disease as he ...
Wausau Daily Herald on MSN
Aspirus E-Visits now cover cold, flu, COVID-19 symptoms, sore throat, insomnia and more
Aspirus Health now offers E-Visits for cold, flu, rash, insomnia and more — making it easier to get care from home.
Metsera's experimental obesity drug showed significant weight loss and favorable tolerability in two mid-stage studies, the drug developer said on Monday.
The water plant chemicals arrived two weeks ago, but there were challenges because of a bad water pump, according to a ...
A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...
If you are diagnosed with the flu and you’re considered high-risk for complications, your doctor will likely recommend that ...
People across the world drink tea, because of its antioxidant properties and its ability to create relaxation. Most people ...
Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback